ClinicalTrials.Veeva

Menu

A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status

Enrolling

Conditions

Cardiovascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT05965882
BIOMS-IHD

Details and patient eligibility

About

The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.

Full description

The purpose of this study is to discover biomarkers for early identification, diagnosis, molecular classification, and intervention based on the mechanism of ischemic heart disease(IHD). Using mass spectrometry-based metabolomics and multimodal imaging technology, the study aims to further construct a new system for early risk stratification of IHD based on abnormal metabolites.

Enrollment

5,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria :

  • Aged 18 years or older.
  • Previous ischemic symptoms/signs or electrocardiographic ischemic changes and.
  • >70% stenosis of at least one epicardial coronary artery on angiography or a history of myocardial infarction or coronary revascularization.

Exclusion Criteria:

  • Current known inability to follow instructions or comply with follow-up procedures.
  • Eligible patients without informed consent form

Trial contacts and locations

1

Loading...

Central trial contact

Yuan Wang, PhD; Yangkai Fan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems